- Home
- WVE vs HEPS Comparison
WVE vs HEPS Comparison
Compare WVE & HEPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WVE
- HEPS
- Stock Information
- Founded
- WVE 2012
- HEPS 2000
- Country
- WVE Singapore
- HEPS Turkey
- Employees
- WVE N/A
- HEPS N/A
- Industry
- WVE Biotechnology: Pharmaceutical Preparations
- HEPS Catalog/Specialty Distribution
- Sector
- WVE Health Care
- HEPS Consumer Discretionary
- Exchange
- WVE Nasdaq
- HEPS Nasdaq
- Market Cap
- WVE 915.6M
- HEPS 883.5M
- IPO Year
- WVE 2015
- HEPS 2021
- Fundamental
- Price
- WVE $6.97
- HEPS $2.87
- Analyst Decision
- WVE Strong Buy
- HEPS
- Analyst Count
- WVE 17
- HEPS 0
- Target Price
- WVE $19.94
- HEPS N/A
- AVG Volume (30 Days)
- WVE 2.4M
- HEPS 176.3K
- Earning Date
- WVE 11-11-2025
- HEPS 07-30-2025
- Dividend Yield
- WVE N/A
- HEPS N/A
- EPS Growth
- WVE N/A
- HEPS N/A
- EPS
- WVE N/A
- HEPS N/A
- Revenue
- WVE $93,946,000.00
- HEPS $1,477,672,859.00
- Revenue This Year
- WVE N/A
- HEPS $37.44
- Revenue Next Year
- WVE $10.02
- HEPS $28.46
- P/E Ratio
- WVE N/A
- HEPS N/A
- Revenue Growth
- WVE N/A
- HEPS 49.45
- 52 Week Low
- WVE $5.28
- HEPS $2.13
- 52 Week High
- WVE $16.74
- HEPS $4.05
- Technical
- Relative Strength Index (RSI)
- WVE 29.71
- HEPS 54.80
- Support Level
- WVE $7.12
- HEPS $2.78
- Resistance Level
- WVE $7.76
- HEPS $2.91
- Average True Range (ATR)
- WVE 0.51
- HEPS 0.09
- MACD
- WVE -0.32
- HEPS 0.00
- Stochastic Oscillator
- WVE 0.57
- HEPS 72.92
About WVE Wave Life Sciences Ltd.
WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.
About HEPS D-Market Electronic Services & Trading
D-MARKET Electronic Services & Trading offers an e-commerce platform in Turkey and the surrounding region. The company is comprised of one reportable segment, namely e-commerce operations. The Group derives revenue from the sales of goods, marketplace revenues and other revenues.